May 24, 2016
Kyowa Hakko Kirin said on May 23 that its investigational chronic kidney disease treatment bardoxolone methyl (RTA402) significantly improved renal functions in a PII clinical study in Japan, dubbed TSUBAKI. The randomized, double-blind, placebo-controlled TSUBAKI study is designed to gauge...read more